Harvey Berman, MD
Psychiatry · Valhalla, NYNPI 1265479943
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 44.3% of the total. Reporting peaked in 2019 at $2,824 and has fallen 70.5% since, to $833 in 2025. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $80.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Johnson & Johnson$2K
- Sunovion Pharmaceuticals Inc.$886
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$794
- Teva Pharmaceuticals USA, Inc.$567
- E.r. Squibb & Sons, L.L.C.$486
- plus $1K from 8 others
What the payments were for
- Food & beverage$10,619100%
- Education$270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 61 | $4,719 |
| Johnson & Johnson | 24 | $1,710 |
| Sunovion Pharmaceuticals Inc. | 15 | $886 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $794 |
| Teva Pharmaceuticals USA, Inc. | 5 | $567 |
| E.r. Squibb & Sons, L.L.C. | 8 | $486 |
| Axsome Therapeutics, Inc. | 3 | $373 |
| Idorsia Pharmaceuticals US Inc | 3 | $271 |
| Otsuka America Pharmaceutical, Inc. | 2 | $247 |
| Alkermes, Inc. | 1 | $125 |
| Jazz Pharmaceuticals Inc. | 1 | $125 |
| Neurocrine Biosciences, Inc. | 1 | $123 |
| Corium, LLC | 1 | $122 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $99 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,646 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Venlafaxine Hcl ErVenlafaxine Hcl | 27 | $1,373 |
| Clonazepam | 56 | $773 |
| Bupropion XlBupropion Hcl | 23 | $743 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $738 |
| Oxycodone Hcl | 24 | $656 |
| Escitalopram Oxalate | 23 | $173 |
| Hydromorphone Hcl | 12 | $150 |
| Risperidone | 20 | $142 |
| Tramadol Hcl | 17 | $109 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Valhalla
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Horacio CapoteAmherst$1.1M
- Yadagiri ChepuruYonkers$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.